Atlas Trials

Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia

Clinical trial NCT03118128 · COMPLETED

Trial details

NCT number
NCT03118128
Sponsor
Hospital General de Mexico
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2015-01-01
Primary completion
2016-12-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.